HCPCS Level II J0395: Arbutamine HCl Injection, 1 mg

HCPCS Level II code J0395 denotes the injectable drug arbutamine hydrochloride, billed per 1 mg unit. As an intravenous cardiovascular agent, arbutamine is used in acute care settings where hemodynamic support or diagnostic pharmacologic stimulation is required. Accurate coding of J0395 is essential for hospitals and clinicians to capture drug administration costs and for payers to adjudicate claims associated with acute cardiovascular care.

This national-level overview covers major payers, including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on the clinical role of arbutamine, typical sites of service where J0395 is billed, and the kinds of billing scenarios in which this HCPCS Level II code appears. The publication also outlines common modifiers and metadata associated with injectable drug billing, and highlights where data was unavailable in the input.

Intended for revenue cycle leaders, clinical coders, and policy analysts, this summary frames what to expect in the full publication: billing benchmarks, payer coverage patterns, and clinical-context considerations relevant to J0395. Data not available in the input will be noted explicitly in the detailed sections.

Billing Code Overview

HCPCS Level II code J0395 represents the injection of arbutamine hydrochloride, with the unit defined as 1 mg. This code is used to report the provision of the medication itself, typically administered intravenously.

Service Type: Drug administration (injectable cardiovascular agent)

Typical Site of Service: Hospital inpatient or outpatient settings, emergency departments, and other acute care settings where IV vasoactive support is provided

Clinical Context

A typical patient is an adult undergoing pharmacologic cardiac stress testing for evaluation of suspected or known coronary artery disease who cannot achieve adequate exercise stress or has contraindications to exercise. The patient presents to an outpatient nuclear cardiology laboratory or hospital diagnostic testing unit. A nuclear medicine technologist or registered nurse prepares and administers J0395 (arbutamine HCl) intravenously under physician supervision while continuous ECG, blood pressure, and symptom monitoring are performed. The supervising cardiologist or nuclear medicine physician prescribes arbutamine dosing titrated to achieve target heart rate or diagnostic endpoints. Imaging with single-photon emission computed tomography (SPECT) or myocardial perfusion imaging is performed before and after pharmacologic stress to assess for ischemia. Common clinical workflow steps include pre-procedure consent and screening for contraindications, IV access placement, baseline vital signs and ECG, incremental arbutamine infusion with monitoring, termination for adverse effects, radiotracer injection if indicated, and post-procedure observation until stable for discharge. Typical sites of service are hospital outpatient departments, freestanding cardiac diagnostic centers, and outpatient imaging centers.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	When work or resources required for administration are substantially greater than usual (e.g., complex IV access, prolonged monitoring) and documented.

Taxonomy Code	Specialty	Notes
`207RP0101X`	Cardiology	Cardiologists commonly order and interpret pharmacologic stress testing.
`207L00000X`	Nuclear Medicine	Nuclear medicine physicians supervise and interpret myocardial perfusion imaging.
`208D00000X`	Diagnostic Radiology	Radiologists may be involved in imaging interpretation in some facilities.
`363A00000X`	Anesthesiology	Anesthesiologists provide anesthesia support when required for high-risk patients.
`170100000X`	Nurse Practitioner	Advanced practice clinicians frequently assist with administration and monitoring.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I20.9`	Angina pectoris, unspecified	Common indication for pharmacologic stress testing when exertional ischemia is suspected.
`I25.10`	Atherosclerotic heart disease of native coronary artery without angina pectoris	Used when evaluating known coronary artery disease for ischemia or perfusion defects.
`I21.9`	Acute myocardial infarction, unspecified	Post-MI patients may undergo stress testing for risk stratification once clinically appropriate.
`R07.9`	Chest pain, unspecified	Symptom prompting diagnostic evaluation with pharmacologic stress imaging when non-exertional or exercise not possible.
`I48.91`	Unspecified atrial fibrillation and atrial flutter	Arrhythmias may necessitate pharmacologic stress testing instead of exercise testing when rate control prevents exercise.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`93000`	Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report	Baseline and continuous ECG monitoring during pharmacologic stress testing.
`78452`	Myocardial perfusion imaging, tomographic (SPECT), single study; with stress and rest imaging, including interpretation	Often performed with arbutamine stress to assess myocardial ischemia.
`78451`	Myocardial perfusion imaging, tomographic (SPECT), single study; stress only, including interpretation	Used when only stress-phase imaging is performed in the workflow.
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	For administration codes when clinic billing requires linking an injection event; note arbutamine is typically billed with `J0395` rather than `96372`.
`36415`	Collection of venous blood by venipuncture	Pre- and post-procedure laboratory testing and monitoring may accompany administration.

OpenPayer

Summary & Overview